Dr. Abhijeet Rajendra Joshi Joins CMT Foundation of India Advisory Board: Advancing Hope for CMT Research in India

The Charcot Marie Tooth Foundation of India (CMTFOI) is delighted to welcome Dr. Abhijeet Rajendra Joshi to its Advisory Board. His association marks an important milestone in our mission to promote research, improve patient care, and accelerate scientific progress for individuals living with Charcot-Marie-Tooth (CMT) disease in India.

Dr. Joshi is an Assistant Professor in the Department of Pharmacy at BITS Pilani, Hyderabad Campus. He earned his Ph.D. in Neuroscience from the University of Cologne, Germany, followed by five years of postdoctoral research at the Baylor College of Medicine, Houston, USA. His work in neuroscience has been recognized through prestigious fellowships, including the DAAD Doctoral Fellowship and the DST INSPIRE Faculty Fellowship, and his research has received international recognition with numerous peer-reviewed publications and over 500 citations.

A Major Step Forward for CMT Research in India

One of the most exciting aspects of Dr. Joshi’s work is his ongoing preclinical research on Charcot-Marie-Tooth Disease Type 2A (CMT2A). Supported by the Indian Council of Medical Research (ICMR), the Department of Science and Technology (DST), and other funding agencies, his laboratory is working on the discovery and preclinical evaluation of novel SARM1 inhibitors, a promising therapeutic approach aimed at slowing or preventing nerve degeneration in CMT2A.

While this research is still at the preclinical stage and is not yet available as a treatment for patients, it represents one of the few dedicated CMT2A research programs currently underway in India. It reflects the growing scientific commitment within the country to develop future therapies for inherited peripheral neuropathies.

Strengthening the Bridge Between Research and Patients

As an Advisory Board Member of CMTFOI, Dr. Joshi will provide scientific guidance to the Foundation’s research initiatives, patient registry, educational programs, and collaborations with clinicians and researchers across India and internationally.

His expertise will help strengthen CMTFOI’s vision of creating a robust ecosystem where patients, clinicians, researchers, and policymakers work together to improve diagnosis, promote research, and prepare India for future clinical trials and emerging therapies.

Looking Ahead

The inclusion of Dr. Abhijeet Rajendra Joshi on the CMTFOI Advisory Board reinforces our commitment to building a strong scientific foundation for the CMT community in India. We believe that meaningful progress is achieved when patient advocacy and cutting-edge research move forward together.

We warmly welcome Dr. Joshi to the CMTFOI family and look forward to working closely with him to advance research, inspire hope, and improve the lives of individuals and families affected by Charcot-Marie-Tooth disease.

Together, we move closer to a future where every CMT patient has access to better diagnosis, better care, and ultimately, better treatments.

-Charcot Marie Tooth Foundation of India